The objective scatter index is a more sensitive tool than the VF-14 screening questionnaire for detecting early cataract, according to a study.The prospective, multicenter study included one eye of each of 1,768 patients being seen for cataract assessm…
The risk of cataracts increases after percutaneous coronary intervention (PCI), suggesting the need for eye protection in patients undergoing these procedures, researchers from Taiwan report. Reuters Health Information
Cleveland Clinic researchers, as part of the Cardiothoracic Surgical Trials Network, have found that two common approaches to post-operative atrial fibrillation – rhythm control and rate control – are equally safe and effective.
EyeGate Pharmaceuticals reported an $8.4 million net loss in 2015 compared with $1.6 million in 2014, according to a company press release. Research and development expenses were reported at $2.7 million in 2015 compared with $0.5 million in 2014. The increase was attributed to clinical activity for EGP-437, the company’s leading drug candidate in clinical trials for treatment of anterior uveitis and macular edema.
Acucela has entered into an exclusive licensing agreement with the University of Manchester to develop and commercialize the university’s human rhodopsin-based optogenetic gene therapy to treat retinitis pigmentosa and related conditions, according to a company press release. “We are extremely excited to enter into this collaboration with the University of Manchester and to begin the important development work needed to unlock the potential of optogenetic gene therapy to improve visual function in patients who have lost much of their vision as well as their hope,” Ryo Kubota, MD, PhD, chairman, (Read more...)
Dr Christopher Rapuano reviews surprising and questionable corneal graft survival rates between two surgical techniques. Medscape Ophthalmology